PRESS DIGEST - Wall Street Journal - Jan 24
Jan 24 The following are the top stories in the Wall Street Journal. Reuters has not verified these stories and does not vouch for their accuracy.
Dec 19 Novo Nordisk A/S
* Says received U.S. FDA approval of Tresiba (insulin degludec injection 100 u/ml, 200 u/ml) for use in children and adolescents with diabetes.
* Says Tresiba, first approved by the FDA in September 2015, is now indicated to improve glycaemic control in patients with type 1 and type 2 diabetes from the age of one through to adulthood.
* Source text for Eikon: Further company coverage: (Reporting by Jacob Gronholt-Pedersen; Editing by Greg Mahlich)
KUALA LUMPUR, Jan 24 Malaysia's AirAsia X Bhd on Tuesday said it has become Asia's first low-cost carrier to receive approval to operate scheduled passenger flights to any destination within the United States.
TOKYO, Jan 24 Japanese stocks declined on Tuesday as U.S. President Donald Trump's protectionist policy stance rattled investors while banks led the losses on sliding U.S. and global bond yields.